TD
Tejas Deepak Naphade
About Tejas Deepak Naphade
Data last updated:
Tejas Deepak Naphade has 3 years in corporate governance. Holds Nominee Director and Director roles. Currently with 2 companies, including International Gemmological Institute (India) Limited and Quality Care India Limited. Formerly with 3 companies, such as United Ciigma Institute Of Medical Sciences Private Limited and Condis India Healthcare Private Limited. Engaged in General Business, Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Nominee Director | 26 Jul 2023 | 1999 | Active | |
| Director | 27 Oct 2023 | 1992 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 17 Nov 2023 | 2011 | Active | |
| Nominee Director | 23 Jan 2024 | 2006 | Amalgamated | |
| Nominee Director | 23 Jan 2024 | 1995 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejas Deepak Naphade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Deepak Naphade
Tejas Deepak Naphade has 3 years in corporate governance. Holds Nominee Director and Director roles. Currently with 2 companies, including International Gemmological Institute (India) Limited and Quality Care India Limited. Formerly with 3 companies, such as United Ciigma Institute Of Medical Sciences Private Limited and Condis India Healthcare Private Limited. Engaged in General Business, Healthcare.
Tejas Deepak Naphade is associated with 2 companies as Nominee Director and Director.
Tejas Deepak Naphade has expertise in General Business, Healthcare.
Tejas Deepak Naphade has 3 years in corporate governance.